YES "Akebia Therapeutics Q3 EPS $(0.46) Misses $(0.43) Estimate, Sales $91.98M Miss $99.38M Estimate 8:00 am ET November 12, 2019 (Benzinga)
Akebia Therapeutics (NASDAQ:AKBA) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.43) by 6.98 percent. This is a 23.33 percent increase over losses of $(0.6) per share from the same period last year. The company reported quarterly sales of $91.98 million which missed the analyst consensus estimate of $99.38 million by 7.45 percent. This is a 73.00 percent increase over sales of $53.169 million the same period last year."
8:53 am ET
*Akebia Reports Secured $100M Non-Dilutive Term Loan Financing(Benzinga)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.